News Focus
News Focus
Replies to #72263 on Biotech Values
icon url

DewDiligence

01/27/09 9:07 AM

#72277 RE: ThomasS #72263

Re: Repros Therapeutics Inc. Announces Information In Compliance With NASDAQ Marketplace Rule 4350

I haven’t checked the fine print of Rule 4350, but I presume that it specifies a time limit for making the going concern disclosure and I presume that the time limit is less than 316 days (the elapsed time since RPRX filed its 2007 10K). In other words, I suspect that the header of today’s PR is false insofar as the company never actually complied with Rule 4350.